Epsilon M&A Deal Report - HRA Pharma Rare Diseases
Transaction Multiples for the Valuation of Private Companies
Esteve Pharmaceuticals / HRA Pharma Rare Diseases
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ![]() |
![]() |
![]() |
|||||
Current |
![]() |
Multiple available |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 32
Date | Acquirer | Target | Country | Multiples | See details |
05/06/2024 | Rohto Pharmaceuticals Co | MoNo chem-pharm Produkte (Sigmapharm) | Austria | * | 117090 |
27/03/2024 | Private group led by Carvest, Siparex | Capron Podologie | Saône-Et-Loire | * | 116883 |
Source: Epsilon Research / EMAT